Measurement-Based Care in the Treatment of Attention-Deficit/Hyperactivity Disorder and Disruptive Behavior Disorders - 02/09/20
, Joseph Blader, PhD b, Vamsi K. Kalari, MD a, Victor M. Fornari, MD, MS aRésumé |
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood psychiatric diagnoses. The core symptoms of ADHD include inattention, impulsivity, and hyperactivity. ADHD entails impairments that have extensive and profound detrimental effects on many critical developmental areas. As a valid neurobiologic condition that causes significant impairments in those affected, it is one of the best-researched disorders in medicine. Measurement-based care in treatment of ADHD is critical in establishing a diagnosis, determining a treatment target, and assessing treatment response. This article highlights the rationale for measurement-based care in ADHD, how to implement measurement-based care in clinical practice, and common challenges encountered.
Le texte complet de cet article est disponible en PDF.Keywords : Attention-deficit/hyperactivity disorder (ADHD), Measurement based care, Children and adolescents, Disruptive behavior disorders, Evidence-based medicine
Plan
Vol 29 - N° 4
P. 663-674 - octobre 2020 Retour au numéro
Article précédent
- Measurement-Based Care in the Treatment of Anxiety
- Courtney Romba, John Lavigne, John Walkup, Rachel Ballard
- Measurement-Based Care in the Treatment of Adolescents with Substance Use Disorders
- Kevin M. Simon, Sion Kim Harris, Lydia A. Shrier, Oscar G. Bukstein
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?